Terms: = Lung cancer AND TSC1, KIAA0243, 7248, ENSG00000165699, TSC, MGC86987, LAM, hamartin AND Treatment
205 results:
1. Lymphangioleiomyomatosis in patients with tuberous sclerosis: a national centre audit.
Johnson J; Somerfield W; Johnson SR
Orphanet J Rare Dis; 2024 Mar; 19(1):137. PubMed ID: 38532450
[TBL] [Abstract] [Full Text] [Related]
2. Patients' and physicians' awareness of clinical symptoms and disease severity in tuberous sclerosis complex.
Sauter M; Weber L; Jung D; Weremko M; Bachmann D; Fischereder M; Bachmann HS
Orphanet J Rare Dis; 2024 Mar; 19(1):106. PubMed ID: 38459571
[TBL] [Abstract] [Full Text] [Related]
3. Phase I Study of mTORC1/2 Inhibitor Sapanisertib (CB-228/TAK-228) in Combination with Metformin in Patients with mTOR/AKT/PI3K Pathway Alterations and Advanced Solid Malignancies.
Subbiah V; Coleman N; Piha-Paul SA; Tsimberidou AM; Janku F; Rodon J; Pant S; Dumbrava EEI; Fu S; Hong DS; Zhang S; Sun M; Jiang Y; Roszik J; Song J; Yuan Y; Meric-Bernstam F; Naing A
Cancer Res Commun; 2024 Feb; 4(2):378-387. PubMed ID: 38126764
[TBL] [Abstract] [Full Text] [Related]
4. Sporadic Lymphangioleiomyomatosis Disease: A Case Report.
Nikmanesh Y; Shokripour M; Mokhtari M; Khazayi M; Monabati A; Rezayi R; Bahtouee M
Iran J Med Sci; 2023 Sep; 48(5):516-521. PubMed ID: 37786468
[TBL] [Abstract] [Full Text] [Related]
5. [Expert consensus on the diagnosis and management of Birt-Hogg-Dubé syndrome].
; ; ;
Zhonghua Jie He He Hu Xi Za Zhi; 2023 Sep; 46(9):897-908. PubMed ID: 37670643
[TBL] [Abstract] [Full Text] [Related]
6. Elevated FBXL6 expression in hepatocytes activates VRK2-transketolase-ROS-mTOR-mediated immune evasion and liver cancer metastasis in mice.
Zhang J; Lin XT; Yu HQ; Fang L; Wu D; Luo YD; Zhang YJ; Xie CM
Exp Mol Med; 2023 Oct; 55(10):2162-2176. PubMed ID: 37653031
[TBL] [Abstract] [Full Text] [Related]
7. New progress of tuberculosis scar carcinoma.
Sun W; Liu Y; Zhao L; Wang H; Ye L; Liu X; Xu K; Chen Y; Fan L
Cancer Metastasis Rev; 2023 Sep; 42(3):653-659. PubMed ID: 37582896
[TBL] [Abstract] [Full Text] [Related]
8. lamC2 promotes EGFR cell membrane localization and acts as a novel biomarker for tyrosine kinase inhibitors (TKIs) sensitivity in lung cancer.
Tong D; Wang X; Liu L; Wen T; Chen Q; Huang C
Cancer Gene Ther; 2023 Nov; 30(11):1498-1512. PubMed ID: 37542131
[TBL] [Abstract] [Full Text] [Related]
9. Lymphangioleiomyomatosis: where endocrinology, immunology and tumor biology meet.
Gibbons E; Minor BMN; Hammes SR
Endocr Relat Cancer; 2023 Sep; 30(9):. PubMed ID: 37410387
[TBL] [Abstract] [Full Text] [Related]
10. Tissue-Engineered Disease Modeling of Lymphangioleiomyomatosis Exposes a Therapeutic Vulnerability to HDAC Inhibition.
Pietrobon A; Yockell-Lelièvre J; Melong N; Smith LJ; Delaney SP; Azzam N; Xue C; Merwin N; Lian E; Camacho-Magallanes A; Doré C; Musso G; Julian LM; Kristof AS; Tam RY; Berman JN; Shoichet MS; Stanford WL
Adv Sci (Weinh); 2023 Sep; 10(26):e2302611. PubMed ID: 37400371
[TBL] [Abstract] [Full Text] [Related]
11. French recommendations for the diagnosis and management of lymphangioleiomyomatosis.
Cottin V; Blanchard E; Kerjouan M; Lazor R; Reynaud-Gaubert M; Taille C; Uzunhan Y; Wemeau L; Andrejak C; Baud D; Bonniaud P; Brillet PY; Calender A; Chalabreysse L; Court-Fortune I; Desbaillets NP; Ferretti G; Guillemot A; Hardelin L; Kambouchner M; Leclerc V; Lederlin M; Malinge MC; Mancel A; Marchand-Adam S; Maury JM; Naccache JM; Nasser M; Nunes H; Pagnoux G; Prévot G; Rousset-Jablonski C; Rouviere O; Si-Mohamed S; Touraine R; Traclet J; Turquier S; Vagnarelli S; Ahmad K;
Respir Med Res; 2023 Jun; 83():101010. PubMed ID: 37087906
[TBL] [Abstract] [Full Text] [Related]
12. Potent saccharinate-containing palladium(II) complexes for sensitization to cancer therapy.
Ouyang R; Wang S; Feng K; Liu C; Silva DZ; Chen Y; Zhao Y; Liu B; Miao Y; Zhou S
J Inorg Biochem; 2023 Jul; 244():112205. PubMed ID: 37028114
[TBL] [Abstract] [Full Text] [Related]
13. Upregulation of acid ceramidase contributes to tumor progression in tuberous sclerosis complex.
Astrinidis A; Li C; Zhang EY; Zhao X; Zhao S; Guo M; Olatoke T; Mattam U; Huang R; Zhang AG; Pitstick L; Kopras EJ; Gupta N; Jandarov R; Smith EP; Fugate E; Lindquist D; Markiewski MM; Karbowniczek M; Wikenheiser-Brokamp KA; Setchell KDR; McCormack FX; Xu Y; Yu JJ
JCI Insight; 2023 May; 8(9):. PubMed ID: 36927688
[TBL] [Abstract] [Full Text] [Related]
14. A multiplexed in vivo approach to identify driver genes in small cell lung cancer.
Lee MC; Cai H; Murray CW; Li C; Shue YT; Andrejka L; He AL; Holzem AME; Drainas AP; Ko JH; Coles GL; Kong C; Zhu S; Zhu C; Wang J; van de Rijn M; Petrov DA; Winslow MM; Sage J
Cell Rep; 2023 Jan; 42(1):111990. PubMed ID: 36640300
[TBL] [Abstract] [Full Text] [Related]
15. Predicting Individualized lung Disease Progression in treatment-Naive Patients With Lymphangioleiomyomatosis.
Palipana AK; Gecili E; Song S; Johnson SR; Szczesniak RD; Gupta N
Chest; 2023 Jun; 163(6):1458-1470. PubMed ID: 36610667
[TBL] [Abstract] [Full Text] [Related]
16. Clinical features and outcomes of male patients with lymphangioleiomyomatosis: A review.
Zhang H; Hu Z; Wang S; Wu K; Yang Q; Song X
Medicine (Baltimore); 2022 Dec; 101(52):e32492. PubMed ID: 36596036
[TBL] [Abstract] [Full Text] [Related]
17. Tuberous Sclerosis Complex: Genetic counselling and perinatal follow-up.
Touraine R; Hauet Q; Harzallah I; Baruteau AE
Arch Pediatr; 2022 Dec; 29(5S):5S3-5S7. PubMed ID: 36585068
[TBL] [Abstract] [Full Text] [Related]
18. Lymphangioleiomyomatosis: a metastatic lung disease.
Kundu N; Holz MK
Am J Physiol Cell Physiol; 2023 Feb; 324(2):C320-C326. PubMed ID: 36571446
[TBL] [Abstract] [Full Text] [Related]
19. Targeting SPHK1/S1PR3-regulated S-1-P metabolic disorder triggers autophagic cell death in pulmonary lymphangiomyomatosis (lam).
Li F; Zhang Y; Lin Z; Yan L; Liu Q; Li Y; Pei X; Feng Y; Han X; Yang J; Zheng F; Li T; Zhang Y; Fu Z; Shao D; Yu J; Li C
Cell Death Dis; 2022 Dec; 13(12):1065. PubMed ID: 36543771
[TBL] [Abstract] [Full Text] [Related]
20. An RNA-seq transcriptome analysis for investigating the anti-lung cancer activity of medicinal
Maimaiti A; Xu J; Shi L
Br J Nutr; 2023 Sep; 130(5):737-749. PubMed ID: 36468438
[No Abstract] [Full Text] [Related]
[Next]
